Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
17%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN XLV
SECTOR DRIFT (XLV minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.9% | 17.8% | 11.9% |
|
JOHNSON & JOHNSON | 8.6% | 11.6% | 8.6% |
|
ABBVIE INC | 7.7% | 5.2% | 5.2% |
|
MERCK & CO. INC. | 4.2% | 6.0% | 4.2% |
|
PFIZER INC | 2.7% | 4.5% | 2.7% |
XLV Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 6.4% |
|
ABBOTT LABORATORIES | 4.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 3.0% |
|
AMGEN INC | 3.0% |
|
GILEAD SCIENCES INC | 2.8% |
|
STRYKER CORP | 2.6% |
|
ABBVIE INC | 2.5% |
|
DANAHER CORP | 2.4% |
XLV Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -7.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.9% |
|
ELI LILLY & CO | -5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.9% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% |
 |
SANOFI-AVENTIS-ADR | -4.3% |
|
JOHNSON & JOHNSON | -3.0% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |
|
CENCORA INC | -2.8% |
|
ZOETIS INC | -2.8% |